These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33450928)

  • 1. Do Adolescent Exposure to Cannabinoids and Early Adverse Experience Interact to Increase the Risk of Psychiatric Disorders: Evidence from Rodent Models.
    Portugalov A; Akirav I
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33450928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the Risks and Consequences of Adolescent Cannabis Exposure.
    Levine A; Clemenza K; Rynn M; Lieberman J
    J Am Acad Child Adolesc Psychiatry; 2017 Mar; 56(3):214-225. PubMed ID: 28219487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Psychiatric Consequences of Cannabinoids.
    De Aquino JP; Sherif M; Radhakrishnan R; Cahill JD; Ranganathan M; D'Souza DC
    Clin Ther; 2018 Sep; 40(9):1448-1456. PubMed ID: 29678279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adolescent exposure to cannabis as a risk factor for psychiatric disorders.
    Rubino T; Zamberletti E; Parolaro D
    J Psychopharmacol; 2012 Jan; 26(1):177-88. PubMed ID: 21768160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Behavioral, cognitive and psychophysiological effects of cannabinoids: relevance to psychosis and schizophrenia].
    Sewell RA; Skosnik PD; Garcia-Sosa I; Ranganathan M; D'Souza DC
    Braz J Psychiatry; 2010 May; 32 Suppl 1():S15-30. PubMed ID: 20512267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders.
    Krebs MO; Kebir O; Jay TM
    Eur J Pain; 2019 Aug; 23(7):1225-1233. PubMed ID: 30793421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids and psychosis.
    Sewell RA; Ranganathan M; D'Souza DC
    Int Rev Psychiatry; 2009 Apr; 21(2):152-62. PubMed ID: 19367509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoids and Psychosis.
    D'Souza DC; Radhakrishnan R; Sherif M; Cortes-Briones J; Cahill J; Gupta S; Skosnik PD; Ranganathan M
    Curr Pharm Des; 2016; 22(42):6380-6391. PubMed ID: 27568729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long lasting consequences of cannabis exposure in adolescence.
    Rubino T; Parolaro D
    Mol Cell Endocrinol; 2008 Apr; 286(1-2 Suppl 1):S108-13. PubMed ID: 18358595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathways to psychosis in cannabis abuse.
    Shrivastava A; Johnston M; Terpstra K; Bureau Y
    Clin Schizophr Relat Psychoses; 2015 Apr; 9(1):30-5. PubMed ID: 23491968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term consequences of adolescent cannabis exposure on the development of cognition, brain structure and function: an overview of animal and human research.
    Jager G; Ramsey NF
    Curr Drug Abuse Rev; 2008 Jun; 1(2):114-23. PubMed ID: 19630711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis and brain function.
    Court JM
    J Paediatr Child Health; 1998 Feb; 34(1):1-5. PubMed ID: 9568931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the impact of adolescent exposure to cannabinoids and nicotine on psychiatric risk: insights from translational animal models.
    Laviolette SR
    Psychol Med; 2021 Apr; 51(6):940-947. PubMed ID: 31801641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis and neuropsychiatry, 1: benefits and risks.
    Andrade C
    J Clin Psychiatry; 2016 May; 77(5):e551-4. PubMed ID: 27249079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis in Adolescence: Lasting Cognitive Alterations and Underlying Mechanisms.
    Scheyer AF; Laviolette SR; Pelissier AL; Manzoni OJJ
    Cannabis Cannabinoid Res; 2023 Feb; 8(1):12-23. PubMed ID: 36301550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoids and psychosis.
    D'Souza DC
    Int Rev Neurobiol; 2007; 78():289-326. PubMed ID: 17349865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strokes are possible complications of cannabinoids use.
    Wolff V; Jouanjus E
    Epilepsy Behav; 2017 May; 70(Pt B):355-363. PubMed ID: 28237318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood.
    Alteba S; Korem N; Akirav I
    Learn Mem; 2016 Jul; 23(7):349-58. PubMed ID: 27317195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety of cannabinoids for the treatment of multiple sclerosis.
    Smith PF
    Expert Opin Drug Saf; 2005 May; 4(3):443-56. PubMed ID: 15934852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.